Sigyn Therapeutics, Inc. financial data

Symbol
SIGY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
9190 W Olympic Blvd # 263, Beverly Hills, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Reign Resources Corp (to 10/23/2020), Reign Sapphire Corp (to 5/12/2020)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.17 % -36.1%
Quick Ratio 1.25 % -25.7%
Debt-to-equity -109 % +5.84%
Return On Equity 106 % -24.6%
Return On Assets -1.15K % -30.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.61M shares
Common Stock, Shares, Outstanding 1.42M shares -96.8%
Entity Public Float 1.86M USD -36.2%
Common Stock, Value, Issued 142 USD -96.8%
Weighted Average Number of Shares Outstanding, Basic 1.27M shares +14.7%
Weighted Average Number of Shares Outstanding, Diluted 1.27M shares +14.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 895K USD +23.8%
General and Administrative Expense 1.86M USD +35.6%
Operating Income (Loss) -2.76M USD -24.8%
Nonoperating Income (Expense) -1.23M USD +23.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.99M USD -4.3%
Net Income (Loss) Attributable to Parent -3.99M USD -4.3%
Earnings Per Share, Basic -3.15 USD/shares +47.1%
Earnings Per Share, Diluted -3.15 USD/shares -14.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 165K USD +155%
Inventory, Net 50K USD 0%
Other Assets, Current 54.3K USD +0.06%
Assets, Current 269K USD +59.4%
Property, Plant and Equipment, Net 11K USD -34.7%
Operating Lease, Right-of-Use Asset 127K USD -30%
Other Assets, Noncurrent 20.7K USD 0%
Assets 427K USD +10.4%
Accounts Payable, Current 612K USD +69.1%
Liabilities, Current 4.28M USD +11.9%
Operating Lease, Liability, Noncurrent 74.7K USD -47.5%
Liabilities 4.35M USD +9.77%
Retained Earnings (Accumulated Deficit) -14.2M USD -39.3%
Stockholders' Equity Attributable to Parent -3.92M USD -9.7%
Liabilities and Equity 427K USD +10.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -236K USD +58.1%
Net Cash Provided by (Used in) Financing Activities 257K USD -70.7%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 1.42M shares -96.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.1K USD -93.3%
Deferred Tax Assets, Valuation Allowance 3.02M USD +80.6%
Operating Lease, Liability 142K USD -29.3%
Depreciation 5.86K USD -14.6%
Lessee, Operating Lease, Liability, to be Paid 153K USD -33.3%
Operating Lease, Liability, Current 67.7K USD +14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 54.2K USD -31.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 79.5K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.8K USD -61.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 54.2K USD +0%
Deferred Tax Assets, Operating Loss Carryforwards 2.78M USD +66.1%
Preferred Stock, Shares Issued 1.15 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 19K USD +3%
Additional Paid in Capital 10.2M USD +55.4%
Preferred Stock, Shares Outstanding 1.15 shares
Amortization of Intangible Assets 2.1K USD -41.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%